BLS Pharmaceuticals Limited (ASX:BLS)
Australia · Delayed Price · Currency is AUD 0.9850
-0.0400 (-3.90%)
Nov 2, 2026, 4:10 PM AEDT
BLS Pharmaceuticals Market Cap
BLS Pharmaceuticals has a market cap or net worth of 226.85 million as of November 2, 2026. It is the 22,137th most valuable company in the world and the 441st biggest in Australia. Its market cap has increased by 158.98% in one year.
Market Cap
226.85M
Enterprise Value
221.99M
Revenue
73.91M
Global Rank
Country Rank
#441 Australia
PE Ratio
14.70
ChartMarket Cap Chart
Since April 10, 2012, BLS Pharmaceuticals's market cap has increased from 31.38M to 226.85M, an increase of 622.92%. That is a compound annual growth rate of 14.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 226.85M | 142.70% |
| Dec 31, 2025 | 93.47M | 68.93% |
| Dec 31, 2024 | 55.33M | 164.50% |
| Dec 29, 2023 | 20.92M | 30.94% |
| Dec 29, 2022 | 15.98M | -13.94% |
| Dec 31, 2021 | 18.56M | 141.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clarity Pharmaceuticals | 585.74M |
| Clinuvel Pharmaceuticals | 364.09M |
| Racura Oncology | 302.93M |
| Tetratherix | 291.82M |
| Starpharma Holdings | 215.88M |
| Actinogen Medical | 161.61M |
| Paradigm Biopharmaceuticals | 153.48M |
| Orthocell | 149.82M |